Eton Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -95.9% | +55,879.5% | -2.7% | +48.9% | +23.3% | +104.9% | |
| – | +384.6% | +619.0% | -36.9% | +817.1% | +164.3% | +52.6% | +47.4% | +138.5% | |
| – | – | – | -148.8% | – | -25.5% | +47.1% | +11.2% | +82.6% | |
| – | +43.2% | +105.3% | +22.1% | -55.8% | -35.9% | -16.9% | -2.0% | +138.6% | |
| – | -2.8% | +60.9% | +69.0% | +13.4% | +28.4% | +1.9% | +20.2% | +57.4% | |
| – | +44.6% | +85.1% | +40.6% | -22.9% | +9.1% | -1.4% | +16.9% | +64.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +71.3% | +216.4% | +17.2% | -8.3% | +11.0% | +89.2% | +138.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +17.1% | -24.4% | -67.5% | -93.9% | +186.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -409.9% | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.